Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Mahickra Chem.
Quarter-by-quarter operating performance
Financials of Mahickra Chem.
Annual income statement trend
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales + | 19.52 | 80.02 | 94.28 | 86.49 | 102.28 | 103.01 | 71.92 | 88.16 | 92.41 |
| Expenses + | 18.75 | 78.98 | 93.70 | 84.38 | 100.53 | 100.59 | 71.25 | 85.66 | 90.75 |
| Operating Profit | 0.77 | 1.04 | 0.58 | 2.11 | 1.75 | 2.42 | 0.67 | 2.50 | 1.66 |
| OPM % | 3.94% | 1.30% | 0.62% | 2.44% | 1.71% | 2.35% | 0.93% | 2.84% | 1.80% |
| Other Income + | 0.46 | 2.47 | 4.35 | 2.98 | 3.93 | 3.62 | 2.27 | 2.62 | 3.04 |
| Interest | 0.24 | 0.53 | 0.69 | 0.57 | 0.78 | 0.93 | 1.16 | 1.29 | 1.34 |
| Depreciation | 0.05 | 0.07 | 0.10 | 0.12 | 0.25 | 0.55 | 0.28 | 0.30 | 0.31 |
| Profit before tax | 0.94 | 2.91 | 4.14 | 4.40 | 4.65 | 4.56 | 1.50 | 3.53 | 3.05 |
| Tax % | 21.28% | 29.90% | 27.54% | 29.55% | 27.74% | 27.85% | 28.67% | 28.33% | |
| Net Profit + | 0.74 | 2.04 | 2.99 | 3.11 | 3.35 | 3.28 | 1.07 | 2.53 | 2.10 |
| EPS in Rs | 1.44 | 2.82 | 3.68 | 3.83 | 4.12 | 4.04 | 1.32 | 3.11 | 2.59 |
| Dividend Payout % | 0.00% | 0.00% | 8.15% | 5.22% | 15.76% | 16.09% | 22.77% | 6.42% |
Financials of Mahickra Chem.
Capital structure and asset base
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.13 | 7.23 | 8.12 | 8.12 | 8.12 | 8.12 | 8.12 | 8.12 | 8.12 |
| Reserves | 2.64 | 7.84 | 15.86 | 18.81 | 21.63 | 24.37 | 25.20 | 27.57 | 28.48 |
| Borrowings + | 6.34 | 4.80 | 5.55 | 10.56 | 10.02 | 10.08 | 13.44 | 15.30 | 14.90 |
| Other Liabilities + | 20.50 | 23.23 | 20.90 | 20.21 | 25.39 | 20.91 | 14.02 | 17.28 | 19.87 |
| Total Liabilities | 34.61 | 43.10 | 50.43 | 57.70 | 65.16 | 63.48 | 60.78 | 68.27 | 71.37 |
| Fixed Assets + | 0.67 | 0.79 | 0.85 | 0.96 | 1.68 | 4.48 | 4.59 | 5.15 | 5.02 |
| CWIP | 0.00 | 0.00 | 2.15 | 2.56 | 2.93 | 0.43 | 0.70 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.05 | 0.05 | 0.05 |
| Other Assets + | 33.94 | 42.31 | 47.43 | 54.18 | 60.55 | 58.52 | 55.44 | 63.07 | 66.30 |
| Total Assets | 34.61 | 43.10 | 50.43 | 57.70 | 65.16 | 63.48 | 60.78 | 68.27 | 71.37 |
Financials of Mahickra Chem.
Operating, investing and financing cash movement
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | -11.15 | -4.23 | -3.47 | -2.50 | 3.24 | 2.32 | -1.33 | -0.19 |
| Cash from Investing Activity + | -0.72 | -0.20 | -2.50 | -0.63 | -1.44 | -0.91 | -0.66 | -0.16 |
| Cash from Financing Activity + | 13.14 | 3.22 | 5.99 | 3.13 | -1.82 | -1.40 | 1.95 | 0.40 |
| Net Cash Flow | 1.27 | -1.20 | 0.01 | 0.00 | -0.02 | 0.00 | -0.03 | 0.05 |
| Free Cash Flow | -11.87 | -4.43 | -5.79 | -3.13 | 1.89 | 1.46 | -1.99 | -0.35 |
| CFO/OP | -1,417% | -328% | -397% | -59% | 259% | 149% | -75% | 21% |
Financials of Mahickra Chem.
Working capital efficiency and return ratios
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 312.83 | 107.69 | 106.04 | 142.94 | 135.96 | 130.29 | 119.16 | 105.78 |
| Inventory Days | 212.44 | 42.23 | 48.98 | 70.98 | 72.06 | 77.95 | 143.12 | 149.95 |
| Days Payable | 416.27 | 111.00 | 83.18 | 89.26 | 97.69 | 76.52 | 71.90 | 73.36 |
| Cash Conversion Cycle | 109.00 | 38.93 | 71.84 | 124.65 | 110.34 | 131.73 | 190.39 | 182.37 |
| Working Capital Days | 116.31 | 66.37 | 81.92 | 101.33 | 92.71 | 99.92 | 139.97 | 121.47 |
| ROCE % | 20.25% | 19.55% | 14.83% | 14.06% | 13.72% | 5.96% | 9.86% |
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…